Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Collagen turnover in bone diseases.

Simon P Robins1

  • 1Matrix Biochemistry, Rowett Research Institute, Bucksburn, Aberdeen AB21 9SB, Scotland, UK. s.robins@rri.sari.ac.uk

Current Opinion in Clinical Nutrition and Metabolic Care
|December 24, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of Pyridinoline Trivalent Collagen Cross-Links by Raman Microspectroscopy.

Calcified tissue international·2017
Same author

PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures.

Bone·2011
Same author

Quantitative measurement of mature collagen cross-links in human carotid artery plaques.

Atherosclerosis·2010
Same author

Identification of damaged proteins in human serum using modified Ehrlich's reagent to target protein-bound pyrroles.

Analytical biochemistry·2009
Same author

A connective tissue disorder caused by mutations of the lysyl hydroxylase 3 gene.

American journal of human genetics·2008
Same author

Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes.

Journal of cell science·2006

New biochemical markers for collagen turnover aid in diagnosing and managing bone disorders like osteoporosis. These advances improve fracture risk assessment and therapy monitoring.

Area of Science:

  • Biochemistry
  • Orthopedics
  • Metabolic Bone Disease

Background:

  • Collagen is the primary protein in bone, and its metabolites are key biochemical markers.
  • Assessing collagen turnover is crucial for diagnosing and managing bone disorders.
  • Advancements in non-collagenous markers also impact bone metabolism assessment.

Purpose of the Study:

  • To review recent advancements in techniques for assessing collagen turnover.
  • To highlight the role of collagen turnover in bone disorder diagnosis and management.
  • To contextualize collagen markers alongside emerging non-collagenous markers.

Main Methods:

  • Development of new bone metabolism markers using age-dependent aspartyl residue isomerisation and racemisation.
  • Measurement of the ratio between newly synthesized and mature collagen.

Related Experiment Videos

  • Application of bone resorption assays for disease monitoring.

    • Main Results:

    • Novel markers provide a new indicator of fracture risk in osteoporosis by measuring collagen synthesis and maturation ratios.
    • Improved understanding of biological variability, particularly dietary effects, enhances assay applicability.
    • Bone resorption assays are effective in monitoring novel therapeutic interventions.

    Conclusions:

    • New assays facilitate enhanced monitoring of collagen metabolism in bone diseases.
    • Better understanding of biological variability improves clinical utility for disease detection and therapy monitoring.
    • Aligning commercial assay development with clinical expectations is a future challenge.